Literature DB >> 12801804

Identification of a new mechanism for bacterial uptake at mucosal surfaces, which is mediated by dendritic cells.

M Rescigno1.   

Abstract

Dendritic cells are potent activators of the immune response. They reside in tissues which interface the external environment, but we shall see that they do not perform only a passive role by monitoring microorganisms that have entered the body. Rather, DC can actively participate to microbial entry across mucosal surfaces by creeping between epithelial cells and by internalizing bacteria via their dendrites.

Mesh:

Year:  2003        PMID: 12801804     DOI: 10.1016/s0369-8114(03)00100-7

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  5 in total

Review 1.  In vivo function of Langerhans cells and dermal dendritic cells.

Authors:  Daniel H Kaplan
Journal:  Trends Immunol       Date:  2010-10-28       Impact factor: 16.687

2.  MyD88 adaptor-like (Mal) functions in the epithelial barrier and contributes to intestinal integrity via protein kinase C.

Authors:  S C Corr; E M Palsson-McDermott; I Grishina; S P Barry; G Aviello; N J Bernard; P G Casey; J B J Ward; S J Keely; S Dandekar; P G Fallon; L A J O'Neill
Journal:  Mucosal Immunol       Date:  2013-04-24       Impact factor: 7.313

3.  Intestinal Host-Microbe Interactions under Physiological and Pathological Conditions.

Authors:  Rodrigo Bibiloni; Eduardo J Schiffrin
Journal:  Int J Inflam       Date:  2010-09-29

4.  Solitary intestinal lymphoid tissue provides a productive port of entry for Salmonella enterica serovar Typhimurium.

Authors:  Stephan Halle; Dirk Bumann; Heike Herbrand; Yvonne Willer; Sabrina Dähne; Reinhold Förster; Oliver Pabst
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

5.  Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions.

Authors:  Olga Schulz; Elin Jaensson; Emma K Persson; Xiaosun Liu; Tim Worbs; William W Agace; Oliver Pabst
Journal:  J Exp Med       Date:  2009-12-14       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.